Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHARMAINE LN KWEI

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1750810495
CMS profile
11000578
Location
KALAMAZOO, MI

General Payments · PY2021–2023

$523.53

  • Reported across 34 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$225.63

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $225.63 17

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $225.63 17

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $57.08 3
PY2022 $240.82 14
PY2023 $225.63 17

Payment records · PY2023 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novo Nordisk Inc $6.46 01/27/2023 Food and Beverage Undisputed 01/23/2026 1001574775 CMS
Novo Nordisk Inc $2.89 02/01/2023 Food and Beverage Undisputed 01/23/2026 1001574701 CMS
Novo Nordisk Inc $4.80 02/10/2023 Food and Beverage Undisputed 01/23/2026 1001574715 CMS
Novo Nordisk Inc $5.39 03/15/2023 Food and Beverage Undisputed 01/23/2026 1001574731 CMS
Novo Nordisk Inc $13.24 05/06/2023 Food and Beverage Undisputed 01/23/2026 1001573501 CMS
Novo Nordisk Inc $7.14 05/24/2023 Food and Beverage Undisputed 01/23/2026 1001573413 CMS
Novo Nordisk Inc $6.69 05/31/2023 Food and Beverage Undisputed 01/23/2026 1001574791 CMS
Novo Nordisk Inc $5.85 06/14/2023 Food and Beverage Undisputed 01/23/2026 1001574757 CMS
Novo Nordisk Inc $5.39 06/21/2023 Food and Beverage Undisputed 01/23/2026 1001574743 CMS
Novo Nordisk Inc $8.33 08/29/2023 Food and Beverage Undisputed 01/23/2026 1001573445 CMS
Novo Nordisk Inc $2.21 09/15/2023 Food and Beverage Undisputed 01/23/2026 1001574685 CMS
Novo Nordisk Inc $8.53 09/21/2023 Food and Beverage Undisputed 01/23/2026 1001573457 CMS
Novo Nordisk Inc $16.50 09/22/2023 Food and Beverage Undisputed 01/23/2026 1001573515 CMS
Novo Nordisk Inc $7.50 10/25/2023 Food and Beverage Undisputed 01/23/2026 1001573429 CMS
Novo Nordisk Inc $105.51 11/15/2023 Food and Beverage Undisputed 01/23/2026 1001573529 CMS
Novo Nordisk Inc $9.00 11/17/2023 Food and Beverage Undisputed 01/23/2026 1001573472 CMS
Novo Nordisk Inc $10.20 12/18/2023 Food and Beverage Undisputed 01/23/2026 1001573487 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.